IL4 and hematoma: Xu et al. (2020) have found that the treatment of intranasal delivery of IL-4 nanoparticles activating the IL-4/STAT6 axis improved extended functional recuperation and hematoma resolution in collagenase- and blood-induced ICH mice models.